Walleye Trading
STAB

Walleye Trading’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Walleye Trading’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,900
Closed -$10K – 5980
2015
Q4 		$10K Buy
+2,900
New +$11.7K ﹤0.01% 4741

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Winfield Associates Cleveland, Ohio $276M AUM 15.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's STAB Position: Q1 2016 in Review

Walleye Trading sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2016, closing a stake of 2,900 shares — an estimated $10K sold.

Walleye Trading first reported a position in STAB in Q4 2015 and held it in 1 quarter. The position peaked at $10K in Q4 2015. 22 funds tracked by Wall St. Rank hold STAB as of Q1 2016.

  • Walleye Trading reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Walleye Trading sold 2,900 Statera Biopharma, Inc. Common Stock shares in Q1 2016, an estimated $10K.
  • Walleye Trading first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • Walleye Trading's Statera Biopharma, Inc. Common Stock position peaked at $10K in Q4 2015.
  • 22 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2016.

Based on Walleye Trading's 13F filing for Q1 2016, filed 16 May 2016.